Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks
Authors:
- Shilpa GattuSGShilpa Gattu
- Judith HongJHJudith Hong
- Arianne Chavez-FrazierACArianne Chavez-Frazier
- Grace D. BandowGBGrace D. Bandow
- Farah MalickFMFarah Malick
- Greg KricorianGKGreg Kricorian
- John KooJKJohn Koo
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 61 (5) , 793-798
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long‐term PUVA therapyInternational Journal of Dermatology, 2004
- The risk of melanoma in association with long-term exposure to PUVAJournal of the American Academy of Dermatology, 2001
- PUVA and cancer risk: the Swedish follow-up studyBritish Journal of Dermatology, 1999
- Risk of Squamous Cell Carcinoma and Methoxsalen (Psoralen) and UV-A Radiation (PUVA)Archives of Dermatology, 1998
- Oral Psoralen and Ultraviolet-A Light (PUVA) Treatment of Psoriasis and Persistent Risk of Nonmelanoma Skin CancerJNCI: Journal of the National Cancer Institute, 1998
- A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasisBritish Journal of Dermatology, 1998
- PhotochemotherapyClinics in Dermatology, 1997
- Non-Melanoma Skin Cancer Occurring in Patients Treated With PUVA Five to Ten Years After First TreatmentJournal of Investigative Dermatology, 1988
- Oral Methoxsalen Photochemotherapy for The Treatment of Psoriasis: a Cooperative Clinical TrialJournal of Investigative Dermatology, 1977
- Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet LightNew England Journal of Medicine, 1974